Author Information
Michael Hoelscher is a distinguished researcher in the field of Infectious Diseases, affiliated with the Division of Infectious Diseases and Tropical Medicine at the Medical Centre of the University of Munich (LMU) in Germany. He is also associated with the German Centre for Infection Research, which underscores his significant role in advancing research in infectious diseases. His work is primarily based in Munich, Germany, where he contributes to both academic and clinical research.Research Contributions
Michael Hoelscher has made substantial contributions to the study of infectious diseases, particularly focusing on viral and bacterial pathogens. In 2022, his research encompassed various aspects of SARS-CoV-2, including antibody responses to different variants and the impact of health measures on COVID-19 testing outcomes. He has also explored other infectious agents such as the tick-borne encephalitis virus and the West-Nile fever virus. His work extends to tuberculosis (TB), as evidenced by his involvement in the UNITE4TB consortium, which focuses on developing new clinical drugs and regimens for TB treatment. His research is characterized by its diversity and relevance to current global health challenges.Aliases
Michael Hoelscher is known by several aliases, which include Michal Hoelscher, M. Hoelscher, M Hoelscher, and Michael Dipl.-ing. Hoelscher. These variations reflect different spellings and abbreviations of his name, which might be used in various publications and professional settings.Publication and Citation Metrics
| Metric |
Value |
| Citation Count |
22,395 |
| h-index |
61 |
| Paper Count |
349 |
